Emil Kaludiev

Suggest Changes
Learn More
BACKGROUND Up to 50% of people with GAD fail to respond to first-line pharmacotherapies for generalized anxiety disorder (GAD), partly due to poor treatment compliance rates and partly due to the(More)
  • 1